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1. Introduction
,4-methylenedioxymethamphetamine 
(MDMA) or ecstasy is one of the most abused 
drugs (Simantov, 2004) among the young 
people worldwide. Although MDMA is as-
sociated with positive feelings and euphoria 
(Nichols, 1986) it is also associated with many side ef-
fects such as hallucinations, depression, reduced learn-
ing and memory loss (Green, Mechan, Elliott, O'Shea, 
& Colado, 2003; Morton, 2005).
3
Introduction MDMA or ecstasy is a derivative of amphetamines used mostly by young 
people worldwide. Although the acute effects of this drug are known, the effect of chronic 
administration is not well studied. Therefor the aim of this study was to determine the effects 
of repeated (long term) administration of MDMA on rats' memory and their hippocampal cell 
density.
Method: Young adult male Wistar rats 200 ± 20 g served as subjects.  The rats were randomly 
distributed into three MDMA treated groups (3×2.5 mg/kg, 3×5 mg/kg, 3×10 mg/kg) and one 
control-saline group. All animals received MDMA intraperitoneally (3h apart; a challenge) 
7th day of every week for consecutive 4 weeks. Animals were trained before and were tested 
after injections for their memory status using the standards passive avoidance method. Finally, 
24hr after the memory test, rats were sacrificed and after tissue operations, the hippocampal 
astrocytes and neurons were counted. 
Results: results showed that the number of neurons in all experimental groups was lower 
than the control-saline group. The most decreased number of neurons was shown in 5 mg/kg 
MDMA group compared to control-saline in all the regions of hippocampus. Also we found 
that repeated administration of MDMA reduced the number of hippocampal astrocytes.
Discussion: It is concluded that repeated administration of MDMA can reduce density of 
neurons and astrocytes and this decrease is not dose dependence.
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MDMA is a synthetic, psychoactive drug that is chem-
ically similar to methamphetamine. MDMA in the adult 
and teenage brains induces neuro-adaptive changes in 
mono-aminergic and glutamatergic systems (Green et 
al., 2003; Kindlundh-Högberg, Schiöth, & Svennings-
son, 2007;  Kindlundh-Högberg, Svenningsson, & 
Schiöth, 2006). Furthermore, the target areas of MDMA 
in the brain includes the cerebral cortex and the hip-
pocampus, which are important areas for learning and 
memory functions (De Letter et al., 2003).
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The effects of MDMA vary according to the dose and 
the frequency and duration of use (Kalant, 2001).
At the microscopic level, administration of MDMA 
inhibits mossy fiber activity in the dentate gyrus (Giorgi 
et al., 2006); a part of hippocampal formation which 
generates neurons throughout life (Fazeli, Gharravi, 
Ghafari, Jahanshahi, & Golalipour, 2008; Jahanshahi, 
Khoshnazar, Azami, & Heidari, 2011). Some studies on 
the animal models have shown that MDMA administra-
tion also impairs adult neurogenesis (Capilla-Gonzalez 
& Hernandez-Rabaza, 2011). It has been reported that 
MDMA can reduce the proliferation rate under some 
administration patterns (Cho et al., 2007).
Also previous studies have shown that the high-dose 
of MDMA leads to neurotoxic effects such as neuronal 
apoptosis, reduced neuronal viability, and mitochondri-
al damage (Jimenez et al., 2004). It has also been shown 
that MDMA induces apoptosis, oxidative stress, and in-
creased transcription of the cellular stress factor c-jun 
in primary cell cultures from the embryonic rat cortex 
(Capela et al., 2006; Stumm et al., 1999).
However the mechanisms of neurotoxic effect of 
MDMA remain poorly understood (Azami et al., 2009).
Astrocyte hypertrophy can occur as a result of neuro-
nal injury and can lead to enhanced expression of GFAP, 
which can be used as a marker of neuronal damage, de-
tected by immunohistochemical analysis of brain slices. 
A few studies have reported an increase in GFAP ex-
pression in the context of MDMA-induced neurotoxic-
ity (Ádori, Andó, Kovács, & Bagdy, 2006; O’Callaghan 
& Miller, 2002; Pubill et al., 2003), whereas others 
have not been able to show this effect (Orio et al., 2004; 
Straiko, Coolen, Zemlan, & Gudelsky, 2007; Wang, 
Baumann, Xu, & Rothman, 2004).  
In this study, we assessed the effects of repeated ad-
ministration of MDMA on passive avoidance memory 
and on neuron-astrocytes density in the hippocampal 
formation in male wistar rats.
2. Methods
2.1. Animals
8-week male Wistar rats (Pasteur Institute, Tehran, 
Iran) weight 200 ± 20 g at the initiation of the study, 
served as subjects. Rats were housed pair-wise in air 
conditioned rooms at 22 ± 3°C and a humidity of 53% 
under a reversed dark-light cycle. The rats were ran-
domly distributed into three MDMA-treated and sham 
groups. All animals received three intraperitoneal in-
jections (3hr apart; a challenge) every 7th day of the 
week for 4 consecutive weeks. MDMA (-3,4- methy-
lenedioxy-N-methamphetamine-HCl, Sigma Pharma-
ceutical) was dissolved in saline on the day of testing. 
During the treatment day the MDMA low-dose group 
received 3×2.5 mg/kg MDMA, the MDMA middle dose 
group received 3×5 mg/kg, the MDMA high-dose group 
received 3×10 mg/kg whereas the control-saline group 
received a vehicle of sterile 0.9% saline solution (1 ml/
kg). Eight animals were used for each group.
The Golestan University of Medical Sciences Guide-
lines for the Care and Use of Animals in Research were 
followed.
2.2. Inhibitory Avoidance Apparatus 
Step-through inhibitory avoidance apparatus consist-
ed of two boxes of the same size (20 × 20 × 30 cm). 
In the middle of a dividing wall, a guillotine door (7.9 
cm2) could be lifted manually. The walls and floor of 
one compartment consisted of white opaque resin and 
the walls of the other compartment were dark. Intermit-
tent electric shocks (50 Hz, 3 s, 1.5 mA intensity) were 
delivered to the grid floor (3 mm in diameter and 1 cm 
intervals) of the dark compartment by an isolated stimu-
lator (Azami et al., 2010).
2.3. Behavioral Procedures 
Our previous study described passive avoidance as 
follows: All animals were allowed to habituate in the 
experimental room (with light and sound attenuated) for 
at least 30 min prior to the experiments. Then, each ani-
mal was gently placed in the brightly lit compartment of 
the apparatus; after 5 s the guillotine door was opened 
and the animal was allowed to enter the dark module 
(Azami et al., 2010). 
The latency with which the animal entered the dark 
chamber was recorded. Animals that waited more than 
120 s to enter the dark chamber were excluded from the 
experiment. 
Once the animal entered with all four-paws to the next 
chamber, the guillotine door was closed and the rat was 
immediately withdrawn from the compartment. This tri-
al was repeated after 30 min. As in the acquisition trial, 
after 5s the guillotine door was opened, and as soon as 
the animal entered the dark (shock) compartment the 
door was closed; and a foot shock (50 Hz, 1 mA and 
D
ow
nl
oa
de
d 
fro
m
 h
ttp
://
jou
rna
ls.
tum
s.a
c.i
r/ a
t 1
3:1
1 I
RS
T o
n T
ue
sd
ay
 M
arc
h 5
th 
20
13
59
Basic and Clinical
February 2013, Volume 4, Number 1
3 s) was immediately delivered to the grid floor of the 
dark room. After 20 s, the rat was removed from the ap-
paratus and placed temporarily into its home cage. Two 
minutes later, the animal was retested in the same way 
as in the previous trials; if the rat did not enter the dark 
compartment during 120 s, a successful acquisition of 
inhibitory avoidance response was recorded. Otherwise, 
when the rat entered the dark compartment (before 120 
s) a second time, the door was closed and the animal re-
ceived the shock again. After retesting, if the rat learned 
inhibitory avoidance response successfully, it was 
moved to the cage and 24h after the training received 
MDMA or saline (3 h apart; a challenge) every 7th day 
for 4 weeks (i.p.). On the test day (4 weeks after train-
ing) each animal was gently placed in the light compart-
ment and after 5 s the door was opened and step through 
latency (sec) was recorded in the absence of electric foot 
shocks, as indicator of inhibitory avoidance behavior.
2.4. Histology 
24 h after the testing sessions, rats were anaesthetized 
with chloroform, decapitated and their brains were 
re¬moved from the skull and stored in paraformalde-
hyde (4%) for two weeks. Then, the brains were placed 
in tissue processor apparatus for tissue procedures. 
Fol¬lowing this session, samples of the brain were 
embed¬ded in paraffin and kept in refrigerator. Then the 
brains were sliced coronally into 8 μm sections (from 
Bregma –2.5 mm to –4.5 mm of the hippocampal for-
mation) (Paxinos & Watson, 2007) with a rotary micro-
tome (MK 1110) and the sections were stained with cre-
syl violet for neurons (Fig.1) and PTAH for astrocytes 
(Fig.2) in accordance with rou¬tine laboratory proce-
dures (Bancroft, Stevens, & Turner, 2008). A photo-
graph of each section was produced using an Olympus 
BX 51 microscope and a DP 12 digital cam¬era under a 
magnification of 1000 for Dentate Gyrus (DG) area and 
400 for other areas. To measure the area density of the 
neurons and astrocytes, the images were trans¬ferred to 
a computer. Using OLYSIA Autobioreporter software, 
Olympus Co, appropriate grids were su¬perimposed 
on the pictures and the cells were counted manually. 
To perform an unbiased measurement, the individual 
was double-blinded and only the cells with significant 
granule cell characteristics were counted (Emamian et 
al., 2010; Jahanshahi, Golalipour, & Afshar, 2009; Jah-
anshahi, Sadeghi, Hosseini, Naghdi, & Marjani, 2010; 
Jahanshahi, Sadeghi, Hosseini, & Nashdi, 2007). 
2.5. Statistical Analysis 
The data were expressed as mean ± SD. The sta¬tistical 
analysis was performed using one and two way analysis 
of variance (ANOVA) using SPSS software. Post-hoc 
comparison of means was carried out with the Tukey 
test for multiple comparisons, when appropriate. The 
level of statistical significance was set at P < 0.05.
3. Results
3.1. Avoidance Inhibitory Memory Test
The results of the memory task at the end of the 4th 
week for all groups are presented in table 1. As shown 
in table 1, the control-saline rats, which had not received 
MDMA, showed the lower latency entrance in the dark 
chamber after four weeks. In contrast, the other groups 
showed more latency compared the sham group. The 
most latency was observed in the 10 mg/kg group. We 
found significant difference between sham and experi-
mented groups except the 5 mg/kg group (P < 0.05). 
The mean of latency to entrance in dark chamber 
showed that MDMA at 10 mg/kg could be reminis-
cent of the shock in the dark chamber, while we did not 
found this phenomenon at the 5 mg/kg group.
Table 1. Table 1: Mean and SD of latency (Sec.) between control-saline and MDMA treated groups. A 
difference of p≤0.05 between the experimental groups was considered statistically significant. The 10 
mg/kg group has the highest latency. 
   Groups Mean (Sec.). Std. Deviation P value
Control-saline 68.75 4.633
MDMA 2.5 mg/kg 190.85 12.865 0.033
MDMA 5 mg/kg 160.87 5.489 0.073
MDMA 10 mg/kg 267.28 14.096 0.002
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Figure 1. Photographs of coronal sections throughout the CA1 area of hippocampus in all groups (Cre-
syl violet staining ×40, neurons are blue)
A: Control-saline B: MDMA 2.5 mg/kg   C: MDMA 5 mg/kg   D: MDMA 10 mg/kg
The highest decrease in the number of neurons was shown in response to MDMA with the dose of 5 
mg/kg compared to the control-saline
Figure 2. Photographs of coronal sections throughout the CA1 area of hippocampus in all groups 
(PTAH staining ×40, Astrocytes are purple)
A: Control-saline  B: MDMA 2.5 mg/kg   C: MDMA 5 mg/kg   D: MDMA 10 mg/kg
The highest decrease in astrocytes number was shown in response to 5 mg/kg dose of MDMA com-
pared to the control-saline
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Figure 3. Significant difference in the number of neurons between sham (Control-saline) 
and MDMA treated groups in all areas of the hippocampus
Figure 4. Significant difference in the number of astrocytes between sham (Control-saline) 
and MDMA treated groups in all areas of the  hippocampus
3.2. Cell Counts 
Fig.3 shows the results of cell counts (neurons) in dif-
ferent groups. The number of neurons in all experimen-
tal groups was lower than in the control-saline group 
and the differences were significant (P < 0.05).
The highest decrease in the number of neurons was 
shown in response to MDMA with the dose of 5 mg/
kg compared to the control-saline, in all regions of the 
hippocampus.
We found that the number of astrocytes in all areas 
of hippocampus reduced compared to the sham group 
(Fig. 4). The highest decrease in astrocytes number was 
shown in response to 5 mg/kg of MDMA compared to 
the control-saline, in all regions of the hippocampus (P 
< 0.05).
4. Discussion
This study surveyed the effects of repeated injection 
of MDMA on avoidance memory of rats and its effect 
on hippocampal neurons and astrocytes density. Our re-
sults show that the lowest entrance delay in dark cham-
ber was in the control-saline group that received saline, 
but most delay was shown in the 10 mg/kg MDMA 
group, probably due to a memory recalling mechanism. 
It seems that this recalling is not dose-dependence, be-
cause the maximum effect of MDMA was seen with 5 
mg/kg and not 10 mg/kg. Previous studies demonstrated 
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that MDMA can changes some factors in CNS, for ex-
ample, a single administration of MDMA (20 mg/kg, 
i.p) can reduce 5- hydroxytryptamine (5-HT) content 
and [3H]paroxetine-labeled 5-HT transporter density 
in the frontal cortex, striatum and hippocampus by 40-
60%, 1 week later. It can also increase glial fibrillary 
acidic protein (GFAP) immunoreactivity in the hippo-
campus (Aguirre, Barrionuevo, Ramírez, Río, & Lash-
eras, 1999), whereas we found different results in the 
number of astrocytes in all areas of  the hippocampus.
The hippocampal dentate gyrus generates neurons 
throughout life and adult hippocampal progenitor cells 
are located at the subgranular zone between the dentate 
hilus and the inner margins of the dentate granule cell 
layer (Fazeli et al., 2008; Jahanshahi et al., 2011). We 
found that MDMA inhibits neurogenesis in dentate gy-
rus, because the number of neurons decreased in experi-
mental groups compared to the saline group. 
In accordance to our study, Cho et al. (2007) found that 
oral treatment with MDMA (1.25, 5, 20, 40 mg/kg) or 
saline for 30 days, dose dependently induced a decrease 
in the number of BrdU-positive cells in the male and 
female dentate gyrus. Their results suggest that chronic 
exposure to MDMA suppresses cell proliferation in the 
dentate gyrus (Cho et al., 2007).
There are some discrepancies in the effects of MDMA 
on the neuronal density, For example, some studies indi-
cate that in Alzheimer’s disease and other chronic neu-
rodegenerative disorders, MDMA (10 –50 mg/kg intra-
peritoneally) enhances the formation of reactive oxygen 
species and induces reactive gliosis in the hippocampus, 
without histological evidence of neuronal loss (Busceti 
et al., 2008). But other evidence indicates that MDMA 
significantly enhances neuronal death in the neonatal rat 
brain. Brain regions mainly affected were the cortex, 
septum, thalamus, hypothalamus and the CA1 region of 
hippocampus. These data suggest that a single injection 
of MDMA (60 mg/kg) causes neurodegeneration in the 
neonatal rat brain (Dzietko et al., 2010).
In addition, neuron apoptosis induced by MDMA and 
the expression of apoptosis-related factors in rat brain 
reported in previous studies, e.g. injection of MDMA 
intraperitoneally (Wang et al., 2009) or directly intra 
hippocampus (A. Azami et al., 2009) compared with 
the saline group, induced apoptosis and significantly in-
creased caspase-3 activity.
5. Conclusion
It can be concluded that MDMA has neurodegenera-
tive effect and it can reduce the density of neurons in 
hippocampal formation, probably in a dose and duration 
dependent manner. But it seems that MDMA has vari-
ous effects on astrocytes density. In addition, long-term 
administration of MDMA can compensate recalling the 
passive avoidance memory test compared to the saline 
group. 
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